Patti Doherty, R.N.

Patti Doherty has 20 years experience in clinical research, including leading diagnostic and pharmaceutical clinical studies. Her experience extends to cancer, infectious disease, cardiology, diabetes, and autoimmune disorders, as well as work in the areas of proteomics, microscopy, and point of care diagnostics. Patti has worked with large and small life science companies to identify clinical applications for innovative diagnostic/prognostic tools. She was the Director of Clinical Studies at Exagen Diagnostics and was responsible for the management and implementation of clinical and laboratory studies.

Ms. Doherty held a 10-year position with the New Mexico Department of Health/Epidemiology Division and was involved in the design and operation of HIV/AIDS and Hepatitis studies in ‘at risk’ populations. During her work at Excalibur Technologies (now Convera, Corp. Nasdaq: CNVR), she co-developed a pattern-matching emergency medicine computer program for pediatric intensive care units. Additionally, she worked with the New Mexico Heart Institute in clinical research and has consulted for a biotech company involved in the development of a new class of immunomodulatory drugs.

Ms. Doherty received her degrees from the University of New Mexico and University of Albuquerque.